NeuroRx is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for mood disorders when they are associated with Acute Suicidal Ideation & Behavior (ASIB), such as Bipolar Depression, PTSD.

Our first treatment regimen is NRX-100/NRX-101, it is being developed for Bipolar Depression in patients with Acute Suicidal Ideation & Behavior




The NeuroRx team reaches beyond boundaries, thinks beyond standards and explores beyond borders. We have the courage to try what others have not yet tried.

We are a dynamic start-up, committed to our mission of bringing life saving treatments to patients.  Most of our colleagues operate out of our Radnor-based clinical office, near Philadelphia.


Open Positions:


     No open positions at this time.


However, in the development of pharmaceutical products there are frequent changes. Hence, if you believe you can contribute to our development of NRX-100/NRX-101, we would like to hear from you at




© 2020 NeuroRx, Inc.

*These drugs are investigational and not approved by the US FDA